NCT00349518 2016-02-17Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLBristol-Myers SquibbPhase 2/3 Withdrawn
NCT00103701 2011-04-14BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic LeukemiaBristol-Myers SquibbPhase 1 Completed